From : Maia Nikoleishvili
To : Abhishek Datta <Abhishek.Datta@mylan.in>
Subject : RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan
Cc : Elena Magura <elena.magura@mylan.com>; Prashant Deshpande <Prashant.Deshpande@mylan.in>; Harpal Singh <harpal.singh@mylan.com>; Tamar Gabunia <tgabunia@moh.gov.ge>
Received On : 13.10.2020 07:20

Dear Mr. Abhishek,

Many thanks for your prompt reply.

As we agreed over the phone, please kindly review the price and offer discount, the lowest possible price.

Please, also clarify the terms of delivery and inform us procedure necessary for immediate dispatching the goods.

As for the payment terms, please note that since we are governmental organization, it would be difficult for us to pay the total value of goods in advance. Therefore, kindly request you to consider payment after delivery or 20 percent in advance and 80 percent after receiving the goods.

And also send me all documentation related to the medication.

Thank you once again for your readiness to support Georgia and I believe that this cooperation will be beneficial for both of our sides.

Best regards,

Maia

+995 577272713 (WhatsApp number)

From: Abhishek Datta
Sent: Tuesday, October 13, 2020 9:10 AM
To: Maia Nikoleishvili
Cc: Elena Magura ; Prashant Deshpande ; Harpal Singh ; Tamar Gabunia ; a.dzuliashvili@mfa.gov.ge
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan
Importance: High

 

Dear Maria

 

Greetings from Mylan!

 

Thanks for sharing your requirements for Remdesivir.

 

We would be glad to offer 3000 Vials for 500 patients (i.e. 6 vials/patients). The delivery timelines would be 2-3 weeks (depending of receipt of Export License for Georgia).

 

The offer price would be USD 28.00/vial (Incoterms: CIF Tbilisi).

 

Please do let us know if you need any other information or documents from our side. My contact details are shared in my below signature.

 

Looking forward to hearing from you!

 

Warm Regards

Abhishek Datta

Business Development

Mylan Laboratories Limited

Hyderabad, India

Direct +91 40 3086 6265

Mobile +91 8008553783

 

 

 

 

From: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>
Sent: Saturday, October 10, 2020 3:38 PM
To: Mylan Customer Service <customer.service@mylanlabs.com>; Communications India and EM <Communicationsinem@mylan.com>
Cc: Tamar Gabunia <tgabunia@moh.gov.ge>; Archil Dzuliashvili <a.dzuliashvili@mfa.gov.ge>
Subject: Request from MoH Georgia regarding procuring Remdesivir from Mylan
Importance: High

 

CAUTION: This email originated from outside of the company. Do not click links or open attachments unless you recognize the sender and know the content is safe.

 

Dear Sirs,

I would like to kindly address you from the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia regarding procuring generic form of Remdesivir manufactured by Mylan under a license from Gilead Science Inc.

Considering current epidemiological situation, we are committed to use all existing opportunities, including engagement in the study of Remdesivir for the treatment of the patients with severe acute respiratory syndrome of COVID-19 in order to avoid fatal outcomes in the infected patients as far as possible.

Therefore, we urgently need to procurer  Remdesivir, initially sufficient for 500 eligible patients and kindly request you to provide us with the product price as well as terms and conditions of delivery as early as possible.

We rely on your support and do hope that our cooperation will be fruitful and successful.

Looking forward to receiving your feedback as soon as possible.

Sincerely yours,

 

Maia Nikoleishvili MPA

 

Head of International Relations and Protocol Division

Ministry of IDPs from the Occupied Territories, Labour, Health and Social Affairs of Georgia

Address: 144 Tsereteli ave., 0159 Tbilisi, Georgia

Tel.: +995 32 2510034 (0803)

Cell phone: +995 577272713

E-mail: mnikoleishvili@moh.gov.ge

 

 

 


This email message and any attachments are for the exclusive use of the intended addressee(s). This message may contain confidential, privileged and/or proprietary information, and unauthorized review, use or distribution by persons other than the intended addressee(s) is strictly prohibited and may be unlawful. Unintended transmission does not waive any privilege including attorney-client, attorney work product or claims to confidentiality. If you received this email in error or it was forwarded from recipients who received it in error, please contact me by return message and immediately destroy all electronic, paper and other versions of this message. Thank you.

Please think before you print.  

View in other languages.